AnaptysBio

+$0.69 (+3.64%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AnaptysBio and other ETFs, options, and stocks.

About ANAB

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab.

CEO

Daniel R. Faga

Employees

102

Headquarters

San Diego, California

Founded

2005

ANAB Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

286.18K

High today

$19.75

Low today

$18.24

Open price

$18.90

Volume

234.71K

52 Week high

$37.89

52 Week low

$18.24

ANAB News

BenzingaMay 26

Short Volatility Alert: AnaptysBio, Inc.

On Wednesday, shares of AnaptysBio, Inc. (NASDAQ: ANAB) experienced volatile short activity. After the activity, the stock price went down -3.95% to $19.19. Th

BenzingaMay 24

AnaptysBio's Return On Capital Employed Insights

Benzinga Pro data, AnaptysBio ANAB reported Q1 sales of $970.00 thousand. Earnings fell to a loss of $36.26 million, resulting in a 11.42% decrease from last qu

Analyst ratings

Buy

28.6%

Hold

57.1%

Sell

14.3%

ANAB Earnings

-$1.31

-$0.02

$1.28

$2.57

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

— per share

Actual

Expected Aug 9, After Hours

Why Robinhood?

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. View more

Short Volatility Alert: AnaptysBio, Inc.

AnaptysBio's Return On Capital Employed Insights

57%

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab.